Life science start-up Pantherna Therapeutics receives 7-digit investment
“First-in-Class“ mRNA-therapeutics for vascular diseases:
04-Jul-2019 -
Pantherna Therapeutics secures €3.5 million in a successful seed-financing round.The funds will be used to advance R&D activities and hire additional scientific staff. The Investors are the High-Tech Gründerfonds (HTGF), European Business Angel Prof. Detlev Riesner as well as the European ...
mRNA drugs
seed financing